A novel combination antimetabolite, TAS-102, exhibits antitumor activity in FU-resistant human cancer cells through a mechanism involving FTD incorporation in DNA.
- 1 September 2004
- journal article
- Published by Spandidos Publications in International Journal of Oncology
- Vol. 25 (3), 571-578
- https://doi.org/10.3892/ijo.25.3.571